Retirement Planning Company of New England’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Buy |
32,642
+1,414
| +5% | +$23.7K | 0.24% | 120 |
|
|
2025
Q1 | $480K | Buy |
31,228
+15,393
| +97% | +$237K | 0.24% | 125 |
|
|
2024
Q4 | $349K | Sell |
15,835
-700
| -4% | -$15.4K | 0.17% | 154 |
|
|
2024
Q3 | $298K | Buy |
16,535
+59
| +0.4% | +$1.06K | 0.15% | 168 |
|
|
2024
Q2 | $268K | Sell |
16,476
-202
| -1% | -$3.28K | 0.15% | 172 |
|
|
2024
Q1 | $235K | Sell |
16,678
-55
| -0.3% | -$776 | 0.13% | 193 |
|
|
2023
Q4 | $175K | Buy |
16,733
+449
| +3% | +$4.69K | 0.08% | 223 |
|
|
2023
Q3 | $166K | Sell |
16,284
-2,458
| -13% | -$25.1K | 0.09% | 195 |
|
|
2023
Q2 | $141K | Buy |
18,742
+182
| +1% | +$1.37K | 0.08% | 217 |
|
|
2023
Q1 | $164K | Sell |
18,560
-673
| -3% | -$5.96K | 0.1% | 210 |
|
|
2022
Q4 | $175K | Sell |
19,233
-827
| -4% | -$7.54K | 0.11% | 200 |
|
|
2022
Q3 | $161K | Sell |
20,060
-249
| -1% | -$2K | 0.12% | 194 |
|
|
2022
Q2 | $152K | Buy |
20,309
+855
| +4% | +$6.4K | 0.1% | 204 |
|
|
2022
Q1 | $182K | Buy |
19,454
+992
| +5% | +$9.28K | 0.1% | 221 |
|
|
2021
Q4 | $147K | Buy |
+18,462
| New | +$147K | 0.07% | 257 |
|